Research Roundup

Debbie Rigby rounds up the latest in research news Treatment of obesity with medications binding the glucagon-like peptide 1 receptor The focus of this review is to elucidate the importance of glucagon-like peptide 1 (GLP-1) receptor-binding medications in addressing obesity-related health deteriorations. Higher doses of certain GLP-based drugs have shown superior effectiveness compared to lower

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous ‘An epic achievement.’
Next Fight for pharmacy continues: CAPS